CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes

Abstract Uncovering gene-phenotype relationships can be enabled by precise gene modulation in human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs) and follow up phenotyping using scalable all-optical electrophysiology platforms. Such efforts towards human functional genomics can be...

Full description

Bibliographic Details
Main Authors: Julie L. Han, Yuli W. Heinson, Christianne J. Chua, Wei Liu, Emilia Entcheva
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-023-05627-y
_version_ 1797397836976881664
author Julie L. Han
Yuli W. Heinson
Christianne J. Chua
Wei Liu
Emilia Entcheva
author_facet Julie L. Han
Yuli W. Heinson
Christianne J. Chua
Wei Liu
Emilia Entcheva
author_sort Julie L. Han
collection DOAJ
description Abstract Uncovering gene-phenotype relationships can be enabled by precise gene modulation in human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs) and follow up phenotyping using scalable all-optical electrophysiology platforms. Such efforts towards human functional genomics can be aided by recent CRISPR-derived technologies for reversible gene inhibition or activation (CRISPRi/a). We set out to characterize the performance of CRISPRi in post-differentiated iPSC-CMs, targeting key cardiac ion channel genes, KCNH2, KCNJ2, and GJA1, and providing a multiparametric quantification of the effects on cardiac repolarization, stability of the resting membrane potential and conduction properties using all-optical tools. More potent CRISPRi effectors, e.g., Zim3, and optimized viral delivery led to improved performance on par with the use of CRISPRi iPSC lines. Confirmed mild yet specific phenotype changes when CRISPRi is deployed in non-dividing differentiated heart cells is an important step towards more holistic pre-clinical cardiotoxicity testing and for future therapeutic use in vivo.
first_indexed 2024-03-09T01:15:57Z
format Article
id doaj.art-c1567f50a3794f879ded230e7ed84f5d
institution Directory Open Access Journal
issn 2399-3642
language English
last_indexed 2024-03-09T01:15:57Z
publishDate 2023-12-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj.art-c1567f50a3794f879ded230e7ed84f5d2023-12-10T12:28:28ZengNature PortfolioCommunications Biology2399-36422023-12-016111610.1038/s42003-023-05627-yCRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytesJulie L. Han0Yuli W. Heinson1Christianne J. Chua2Wei Liu3Emilia Entcheva4Department of Biomedical Engineering, The George Washington UniversityDepartment of Biomedical Engineering, The George Washington UniversityDepartment of Biomedical Engineering, The George Washington UniversityDepartment of Biomedical Engineering, The George Washington UniversityDepartment of Biomedical Engineering, The George Washington UniversityAbstract Uncovering gene-phenotype relationships can be enabled by precise gene modulation in human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs) and follow up phenotyping using scalable all-optical electrophysiology platforms. Such efforts towards human functional genomics can be aided by recent CRISPR-derived technologies for reversible gene inhibition or activation (CRISPRi/a). We set out to characterize the performance of CRISPRi in post-differentiated iPSC-CMs, targeting key cardiac ion channel genes, KCNH2, KCNJ2, and GJA1, and providing a multiparametric quantification of the effects on cardiac repolarization, stability of the resting membrane potential and conduction properties using all-optical tools. More potent CRISPRi effectors, e.g., Zim3, and optimized viral delivery led to improved performance on par with the use of CRISPRi iPSC lines. Confirmed mild yet specific phenotype changes when CRISPRi is deployed in non-dividing differentiated heart cells is an important step towards more holistic pre-clinical cardiotoxicity testing and for future therapeutic use in vivo.https://doi.org/10.1038/s42003-023-05627-y
spellingShingle Julie L. Han
Yuli W. Heinson
Christianne J. Chua
Wei Liu
Emilia Entcheva
CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
Communications Biology
title CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
title_full CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
title_fullStr CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
title_full_unstemmed CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
title_short CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes
title_sort crispri gene modulation and all optical electrophysiology in post differentiated human ipsc cardiomyocytes
url https://doi.org/10.1038/s42003-023-05627-y
work_keys_str_mv AT julielhan crisprigenemodulationandallopticalelectrophysiologyinpostdifferentiatedhumanipsccardiomyocytes
AT yuliwheinson crisprigenemodulationandallopticalelectrophysiologyinpostdifferentiatedhumanipsccardiomyocytes
AT christiannejchua crisprigenemodulationandallopticalelectrophysiologyinpostdifferentiatedhumanipsccardiomyocytes
AT weiliu crisprigenemodulationandallopticalelectrophysiologyinpostdifferentiatedhumanipsccardiomyocytes
AT emiliaentcheva crisprigenemodulationandallopticalelectrophysiologyinpostdifferentiatedhumanipsccardiomyocytes